Growth and collagen synthesis inhibition in asthmatic children treated by inhaled corticosteroids;Troubles de la croissance et de la synthese du collagene chez des enfants asthmatiques traites par des steroides en inhalation

Revue Medicale de la Suisse Romande

Volumn 119, Issue 6, 1999, Pages 475-479

  Martin Du Pan, Rémy C ^a,b   Vonlanthen, Marie Claire ^b   Dubuis, Jean Michel ^c  

^a Endocrinologue   (Switzerland)

^b Pédiatre ^*  (Germany)

^c Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; COLLAGEN; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE; SOMATOMEDIN C; THEOPHYLLINE;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADRENAL SUPPRESSION; ARTICLE; ASTHMA; CASE REPORT; CHILD GROWTH; COLLAGEN SYNTHESIS; CORTICOSTEROID THERAPY; DRUG SAFETY; GROWTH RETARDATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; PROTEIN SYNTHESIS INHIBITION;

ADMINISTRATION, INHALATION; ADOLESCENT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; COLLAGEN; GROWTH DISORDERS; HUMANS; MALE;

EID: 0032972940     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. The British guidelines on asthma management 1995 review and position statement. Thorax, 52 (suppl): S1-21, 1997.
2. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehatonen K., Nikander K., Persson T., Selroos O.I., Sovijarvi A. et al.: Effects of reducing or discontinuing inhaled budesonide inpatients with mild asthma. N. Engl. J. Med., 331: 700-705, 1994.
3. Cumming R., Mitchell P., Leeder S.: Use of inhaled corticosteroids and the risk of cataracts. N. Engl. J. Med., 337:8-14, 1997.
4. Todd G., Dunlop K., McNaboe J., Ryan M.F., Carson D., Shields M.D.: Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet, 348:27-29, 1996.
5. Autio P., Karjalainen J., Risteli L. and al.: Effects of an Inhaled steroid (Budesonide) on skin collagen synthesis of asthma patients in vivo. Am. J. Respir. Crit. care Med., 153: 1772-1775, 1996.
6. Pedersen S., O'Byrne P.: A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy, 52 (Suppl. 39): 1-34, 1977.
7. Lundback B., Alexander M., Days J., and al.: Evaluation of fluticasone propionate (500 ug das -1) administered either as dry power via a diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 ug day -1) administered by pressurized inhaler. Resp. Med., 87: 609-620, 1993.
8. Voss L.D., Bailey B.J.R.: Diurnal variation in stature: is stretching the answer? Arch. Dis. Child., 77: 319-322, 1997.
9. Merkus P., van Essen-Zandvliet E., Duiverman E., van Houwelingen H. and al.: Long-term effect of inhaled corticosteroids on growth rate in adolescents with asthma. Pediatrics, 91:1121-1126, 1993.
10. Boersma B., Witt J.M.: Catch-up growth. Endocr. Rev., 18 (5): 646-661, 1997.
11. Simons F.E. and the Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate study group.: A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N. Eng. J. Med., 337: 1659-1665, 1997.
12. Allen D., Bronsky E., Laforce C., Nathan R. and al.: Growth in asthmatic children treated with fluticasone propionate. J. Pediatr, 132: 472-477, 1998.
13. Allen D.B.: Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective. Acta Paediatr., 87: 123-129, 1998.
14. Birkebaek N.H., Esberg G., Andersen K., Wolthers O., Hassager C.: Bone and collagen turnover during treatment with inhaled dry power budesonide and beclomethasone dipropionate. Arch. Dis. Child., 73: 524-527, 1995.
15. Heuck C., Wolthers O.D., Hansen M., Kollerup G.: Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide. Steroids, 62: 659-664, 1997.
16. Wolthers O.D., Hansen M., Juul A., Nielsen H.K. and al.: Knemometry, urine cortisol excretion, and measures of the insulin-like growth factor axis and collagen turnover in children treated with inhaled glucocorticosteroids. Pediatr. Res., 41 : 44-50, 1997.
17. Crowley S., Trivedi P., Risteli L., Risteli J. and al.: Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J. Pediatr., 132: 409-413, 1998.
18. Capewell S., Reynolds S., Shuttleworth D. and al.: Purpura and dermal thinning associated with high dose inhaled corticosteroids. Br. Med. J., 300: 1548-1551, 1990.
19. Edwards C., Bone M., Mak VHF.: Purpura and cutaneous atrophy as side effects of inhaled corticosteroids in asthma therapy: a review. Intern. J. of R. & Saf. in Med., 5: 43-55, 1994.
20. Autio P., Oikarinen A., Melkko J., Risteli J., Risteli L.: Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect. Br. J. Dermatol., 131 (5): 660-663, 1994.
21. Evans DJ., Taylor D.A., Zetterstrom O. and al.: A comparison of low-dose inhaled budesonide plus theo phylline and high-dose inhaled budesonide for moderate asthma. N. Eng. J. Med., 337: 1412-1418, 1997.
22. Navak A.S., Anderson P., Charous B.L., Williams: Equivalence of adding zafirlukast versus double-dose inhaled corticosteroids in asthmatic patients symptomatic on low-dose inhaled corticosteroids. J. Allergy Clin. Immunol., 101 (part 2): S233, 1998.
23. Allen D.B., Julius J.R., Breen T., Attie K.: Treatment of glucocorticoid-induced growth suppression with growth hormone. J. Clin. Endocrinol. Metab., 83: 2824-2829, 1998.
24. Ghigo E., Arvat E., Muccioli G., Camanni F.: Growth hormone-releasing peptides. Eur. J. Endocrinol., 136: 445-460, 1997.